Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 2
2009 3
2010 2
2012 1
2015 1
2016 1
2017 1
2022 2
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Results by year

Filters applied: . Clear all
Page 1
Rheumatoid arthritis in recession.
Alcorn N, Chee MM, Murdoch R, Madhok R. Alcorn N, et al. J Rheumatol. 2009 Jul;36(7):1353-4. doi: 10.3899/jrheum.090571. J Rheumatol. 2009. PMID: 19567629 No abstract available.
Health information on the internet.
Alcorn N, Madhok R. Alcorn N, et al. J Rheumatol. 2012 May;39(5):883-4. doi: 10.3899/jrheum.120136. J Rheumatol. 2012. PMID: 22550003 No abstract available.
Effect of a 2-week interruption in methotrexate treatment versus continued treatment on COVID-19 booster vaccine immunity in adults with inflammatory conditions (VROOM study): a randomised, open label, superiority trial.
Abhishek A, Boyton RJ, Peckham N, McKnight Á, Coates LC, Bluett J, Barber V, Cureton L, Francis A, Appelbe D, Eldridge L, Julier P, Valdes AM, Brooks T, Rombach I, Altmann DM, Nguyen-Van-Tam JS, Williams HC, Cook JA; VROOM study investigators. Abhishek A, et al. Lancet Respir Med. 2022 Sep;10(9):840-850. doi: 10.1016/S2213-2600(22)00186-2. Epub 2022 Jun 27. Lancet Respir Med. 2022. PMID: 35772416 Free PMC article. Clinical Trial.
Effect of a 2-week interruption in methotrexate treatment on COVID-19 vaccine response in people with immune-mediated inflammatory diseases (VROOM study): a randomised, open label, superiority trial.
Abhishek A, Peckham N, Pade C, Gibbons JM, Cureton L, Francis A, Barber V, Williams JAE, Appelbe D, Eldridge L, Julier P, Altmann DM, Bluett J, Brooks T, Coates LC, Rombach I, Semper A, Otter A, Valdes AM, Nguyen-Van-Tam JS, Williams HC, Boyton RJ, McKnight Á, Cook JA; VROOM study investigators. Abhishek A, et al. Lancet Rheumatol. 2024 Feb;6(2):e92-e104. doi: 10.1016/S2665-9913(23)00298-9. Epub 2023 Dec 12. Lancet Rheumatol. 2024. PMID: 38267107 Free article. Clinical Trial.
Promoting science over serendipity in prescribing anti-TNF therapy.
Chee MM, Alcorn N, Paterson K, Madhok R. Chee MM, et al. Among authors: alcorn n. Rheumatology (Oxford). 2009 Aug;48(8):865-6. doi: 10.1093/rheumatology/kep095. Epub 2009 Apr 29. Rheumatology (Oxford). 2009. PMID: 19403738 No abstract available.
A Large Cluster of New Onset Autoimmune Myositis in the Yorkshire Region Following SARS-CoV-2 Vaccination.
De Marco G, Giryes S, Williams K, Alcorn N, Slade M, Fitton J, Nizam S, Smithson G, Iqbal K, Tran G, Pekarska K, Keen MUH, Solaiman M, Middleton E, Wood S, Buss R, Devine K, Marzo-Ortega H, Green M, McGonagle DG. De Marco G, et al. Among authors: alcorn n. Vaccines (Basel). 2022 Jul 26;10(8):1184. doi: 10.3390/vaccines10081184. Vaccines (Basel). 2022. PMID: 35893834 Free PMC article.
13 results